Cargando…

Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis

OBJECTIVE: Intraperitoneal (IP) chemotherapy through subcutaneous port is an effective treatment for gastric cancer (GC) patients with peritoneal metastasis (PM). The objective of this study is to assess the port complications and risk factors for complications in GC patients with PM. METHODS: In re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Zhongyin, Li, Chen, Liu, Wentao, Zheng, Yanan, Zhu, Zhenglun, Hua, Zichen, Ni, Zhentian, Lu, Sheng, Yan, Min, Yan, Chao, Zhu, Zhenggang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491546/ https://www.ncbi.nlm.nih.gov/pubmed/32963462 http://dx.doi.org/10.21147/j.issn.1000-9604.2020.04.07

Ejemplares similares

Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases
por: Shi, Min, et al.
Publicado: (2021)

Colonic stenosis caused by infection of an intraperitoneal access port system: a rare complication of intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis
por: Kinoshita, Jun, et al.
Publicado: (2014)

Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy
por: Xu, Wei, et al.
Publicado: (2021)

Is D2 Lymphadenectomy Alone Suitable for Gastric Cancer With Bulky N2 and/or Para-Aortic Lymph Node Metastases After Preoperative Chemotherapy?
por: Xu, Wei, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy Versus Direct Surgery for Locally Advanced Gastric Cancer With Serosal Invasion (cT4NxM0): A Propensity Score-Matched Analysis
por: Xu, Wei, et al.
Publicado: (2021)

Complications after implantation of subcutaneous central venous ports (PowerPort(Ⓡ))
por: Nakamura, Takatoshi, et al.
Publicado: (2017)

Subcutaneous ICD implant complicated by an intraperitoneal lead course and device infection
por: Kaufmann, Michael R., et al.
Publicado: (2016)

Adjuvant Bidirectional Chemotherapy Using an Intraperitoneal Port
por: Sugarbaker, Paul H., et al.
Publicado: (2012)

Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy
por: Yan, Tristan D, et al.
Publicado: (2006)

Response Evaluation in Patients with Peritoneal Metastasis Treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
por: Roensholdt, Signe, et al.
Publicado: (2023)

Effects of Neoadjuvant Intraperitoneal/Systemic Chemotherapy (Bidirectional Chemotherapy) for the Treatment of Patients with Peritoneal Metastasis from Gastric Cancer
por: Yonemura, Yutaka, et al.
Publicado: (2012)

Reflex Anuria: A Complication of Hyperthermic Intraperitoneal Chemotherapy
por: Fayed, Mohamed, et al.
Publicado: (2021)

Is adjuvant chemotherapy necessary for early gastric cancer?
por: Mei, Yu, et al.
Publicado: (2022)

A Rare Complication of Internal Jugular Vein Cannulation Following Subcutaneous Implanted Port Placement
por: Chacko, Anjo, et al.
Publicado: (2022)

Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Glockzin, Gabriel, et al.
Publicado: (2009)

Gastrointestinal Complications in 147 Consecutive Patients with Peritoneal Surface Malignancy Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy
por: Casado-Adam, Angela, et al.
Publicado: (2011)

Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis
por: Lin, En-Kwang, et al.
Publicado: (2016)

Is Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) Effective in Ovarian Cancer With Peritoneal Metastasis?
por: Mohammad, Amad, et al.
Publicado: (2022)

Investigation of the effectiveness of hyperthermic intraperitoneal chemotherapy in experimental colorectal peritoneal metastasis model
por: Manoğlu, Berke, et al.
Publicado: (2023)

Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review
por: Ploug, Magnus, et al.
Publicado: (2020)

Staging laparoscopy and Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for peritoneal metastasis: safe access to the abdomen
por: Glatz, Torben, et al.
Publicado: (2019)

Single-Port Laparoscopic Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
por: Alshammari, Turki, et al.
Publicado: (2019)

Cutaneous port-site recurrence secondary to tumour seeding following implantation of an intraperitoneal chemotherapy access port for gastric cancer
por: Chue, Koy Min, et al.
Publicado: (2020)

Complications and Mortality Rate of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Italian Peritoneal Surface Malignancies Oncoteam Results Analysis
por: Carboni, Fabio, et al.
Publicado: (2022)

Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies
por: Guchelaar, Niels A. D., et al.
Publicado: (2023)

Establishment of a Mouse Ovarian Cancer and Peritoneal Metastasis Model to Study Intraperitoneal Chemotherapy
por: Rezniczek, Günther A., et al.
Publicado: (2020)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer with Peritoneal Metastasis—Indian Experience
por: S.P, Somashekhar, et al.
Publicado: (2021)

Efficacy and safety of TCM therapies combined with hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of gastric cancer: A protocol for systematic review and meta-analysis
por: Zhu, Xiaoyu, et al.
Publicado: (2021)

Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis
por: Zhang, Xin, et al.
Publicado: (2021)

Wernicke encephalopathy as rare complication of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Macrì, Antonio, et al.
Publicado: (2015)

Anaesthesia considerations and techniques for Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC)
por: Shree, Venkatesan, et al.
Publicado: (2020)

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis
por: Nadiradze, Giorgi, et al.
Publicado: (2015)

Nutritional status, cachexia, and anorexia in women with peritoneal metastasis and intraperitoneal chemotherapy: a longitudinal analysis
por: Hilal, Ziad, et al.
Publicado: (2017)

Systematic Review of Variations in Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Metastasis from Colorectal Cancer
por: Yurttas, Can, et al.
Publicado: (2018)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy as Treatment Options for Peritoneal Metastasis of Advanced Gastric Cancer
por: Kim, Dong-Wook, et al.
Publicado: (2018)

Multicenter Retrospective Analysis of Intraperitoneal Paclitaxel and Systemic Chemotherapy for Advanced Gastric Cancer with Peritoneal Metastasis
por: Kim, Dong-Wook, et al.
Publicado: (2020)

mPEG-PDLLA Micelles Potentiate Docetaxel for Intraperitoneal Chemotherapy in Ovarian Cancer Peritoneal Metastasis
por: Zhang, Yumei, et al.
Publicado: (2022)

Postoperative oxaliplatin-based hyperthermic intraperitoneal chemotherapy: an effective and safe palliative treatment option for colorectal cancer with peritoneal metastasis
por: Sun, Tuanhe, et al.
Publicado: (2021)

Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice.
por: Kondo, A., et al.
Publicado: (1996)

Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis
por: Asmar, Antoine El, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qhq4r3hfnf3p8929biapckknqi